Ewan Eadie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ewan Eadie has a total of 206 co-authors. Here are the top co-authors by number of shared publications:
- Sally Helen Ibbotson
Photobiology Unit, Ninewells Hospital, University of Dundee School of Medicine, Dundee, Scotland, UK
19 shared publications - Paul O'Mahoney
UK Health Security Agency, Centre for Radiation, Chemical Climate and Environmental Hazards, Harwell Campus, Chilton, Didcot, Oxford OX11 0RQ, UK
16 shared publications Kenneth Wood
8 shared publications- Kenneth Wood
SUPA, School of Physics & Astronomy University of St Andrews St Andrews UK
7 shared publications Harry Moseley
Photobiology Unit, Ninewells Hospital & Medical School, University of Dundee, Dundee, UK
6 shared publications- Isla Rose Mary Barnard
Division of Neuroscience, University of Dundee, Ninewells Hospital & Medical School, James Arnott Drive, Dundee, DD2 1SG, UK
5 shared publications
Latest Publications
- Open Access
- 10 October 2026
- Published by Wiley in Photochemistry and Photobiology
Validated computational modeling to evaluate spatial inactivation of airborne pathogens by Far‐ UVC irradiation
Recent experimental studies have indicated the potential for ultraviolet C irradiation at 222 nm (Far‐UVC) to be used in occupied rooms to safely reduce exposure to airborne pathogens. We present simulations coupling Monte Carlo radiation transfer with computational fluid dynamics to predict the spatial variation in airborne microorganism inactivation. Our simulations effectively reproduce data from steady‐state experiments in a room‐sized bioaerosol chamber for the reduction of aerosolized Staphylococcus aureus . Application of the validated model suggests that germicidal Far‐UVC lamps could reduce levels of airborne human coronavirus by more than 90% in rooms with low ventilation rates. Depending on the UVC susceptibility of the aerosolized pathogen, Far‐UVC lamps have the potential to provide in excess of 100 equivalent air changes per hour, much greater than is possible with mechanical ventilation or filtration devices. The success of our simulations at reproducing the experimental data provides confidence that we can simulate larger environments where steady‐state airflow is appropriate and inform best practices for installations of germicidal Far‐UVC lamps.
- 10 October 2026
- Published by Wiley in Photochemistry and Photobiology
Open AccessValidated computational modeling to evaluate spatial inactivation of airborne pathogens by Far‐ UVC irradiation
Recent experimental studies have indicated the potential for ultraviolet C irradiation at 222 nm (Far‐UVC) to be used in occupied rooms to safely reduce exposure to airborne pathogens. We present simulations coupling Monte Carlo radiation transfer with computational fluid dynamics to predict the spatial variation in airborne microorganism inactivation. Our simulations effectively reproduce data from steady‐state experiments in a room‐sized bioaerosol chamber for the reduction of aerosolized Staphylococcus aureus . Application of the validated model suggests that germicidal Far‐UVC lamps could reduce levels of airborne human coronavirus by more than 90% in rooms with low ventilation rates. Depending on the UVC susceptibility of the aerosolized pathogen, Far‐UVC lamps have the potential to provide in excess of 100 equivalent air changes per hour, much greater than is possible with mechanical ventilation or filtration devices. The success of our simulations at reproducing the experimental data provides confidence that we can simulate larger environments where steady‐state airflow is appropriate and inform best practices for installations of germicidal Far‐UVC lamps.
- 17 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Standardizing lesion photography: development and evaluation of the Dundee Image Grading Scale in teledermatology
The rapid expansion of teledermatology has resulted in skin lesion photography being undertaken by an increasingly diverse workforce, leading to substantial variation in technical image quality. We describe the development and evaluation of the Dundee Image Grading Scale, a brief, numeral-based, image quality assessment tool designed specifically for macroscopic lesion photography. The tool demonstrates reliable performance across users with varied clinical and technical backgrounds, while remaining intuitive and efficient to use. We anticipate that this will support future quality assurance activities across services that are dependent on high-quality image capture, such as teledermatology and the emerging artificial intelligence applications for skin cancer diagnosis.
- 17 August 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
Standardizing lesion photography: development and evaluation of the Dundee Image Grading Scale in teledermatology
The rapid expansion of teledermatology has resulted in skin lesion photography being undertaken by an increasingly diverse workforce, leading to substantial variation in technical image quality. We describe the development and evaluation of the Dundee Image Grading Scale, a brief, numeral-based, image quality assessment tool designed specifically for macroscopic lesion photography. The tool demonstrates reliable performance across users with varied clinical and technical backgrounds, while remaining intuitive and efficient to use. We anticipate that this will support future quality assurance activities across services that are dependent on high-quality image capture, such as teledermatology and the emerging artificial intelligence applications for skin cancer diagnosis.
- Open Access
- 1 April 2026
- Published by Springer Nature
Studying how healthy skin reacts to a new LED light device
- 1 April 2026
- Published by Springer Nature
Open AccessStudying how healthy skin reacts to a new LED light device
- Open Access
- 28 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Prospective Multi-Centre Photopatch Test Study of Photoallergy to Sunscreens and NSAIDs in Europe
Background: Whilst photopatch testing is recognized as the investigation of choice for photoallergic contact dermatitis, changes in potential photoallergen exposure and variables within the photopatch test technique, have led to challenges in its usage within dermatology. Objectives: The main objectives of this study were to determine the nature and prevalence of topical photoallergens in Europe and investigate the variable of photoallergen occlusion time before irradiation, on photopatch testing outcomes. Methods: A prospective multi-centre study of photopatch testing to sunscreens, non-steroidal anti-inflammatory drugs (NSAIDs) and other agents was conducted in 10 centres across seven European countries. A within-subject comparison of a 24h and 48h occlusion period prior to irradiation was included in the study design, to investigate the effect of this variable on photopatch testing outcomes. Results: Of study participants, 28 photoallergic reactions were seen, with 10% (13/132) of participants reacting to sunscreen chemicals and 9% (9/101) to NSAIDs. The most prevalent photoallergens were ketoprofen (n=6), promethazine (n=4); butylmethoxydibenzoylmethane (Avobenzone/Parsol 1789) (n=4), benzophenone-3 (oxybenzone) (n=3) and etofenamate (n=3). Contact allergies were less frequent (14 reactions). When a 24h occlusion was used prior to irradiation, 53% of sunscreen photoallergic reactions and 36% of NSAID reactions were missed compared with the 48h occlusion. Most participants had a history of photo-exposed site dermatitis or sunscreen/NSAID reaction or had a photosensitivity disease, and 49% of participants had a history of dermatological conditions. All indications for photopatch testing were represented in those with positive photopatch tests, with no specific indicator of those most at risk. Conclusions: Photopatch testing remains an essential investigation for people with suspected photocontact allergies. Based on these study findings, the nature of topical photoallergens appears stable, but vigilance and ongoing review are required. To optimise the pick-up rate of photoallergy, we recommend, if practicable, a 48h occlusion period prior to irradiation. (Clinicaltrials.gov – NCT03812887)
- 28 March 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
Open AccessProspective Multi-Centre Photopatch Test Study of Photoallergy to Sunscreens and NSAIDs in Europe
Background: Whilst photopatch testing is recognized as the investigation of choice for photoallergic contact dermatitis, changes in potential photoallergen exposure and variables within the photopatch test technique, have led to challenges in its usage within dermatology. Objectives: The main objectives of this study were to determine the nature and prevalence of topical photoallergens in Europe and investigate the variable of photoallergen occlusion time before irradiation, on photopatch testing outcomes. Methods: A prospective multi-centre study of photopatch testing to sunscreens, non-steroidal anti-inflammatory drugs (NSAIDs) and other agents was conducted in 10 centres across seven European countries. A within-subject comparison of a 24h and 48h occlusion period prior to irradiation was included in the study design, to investigate the effect of this variable on photopatch testing outcomes. Results: Of study participants, 28 photoallergic reactions were seen, with 10% (13/132) of participants reacting to sunscreen chemicals and 9% (9/101) to NSAIDs. The most prevalent photoallergens were ketoprofen (n=6), promethazine (n=4); butylmethoxydibenzoylmethane (Avobenzone/Parsol 1789) (n=4), benzophenone-3 (oxybenzone) (n=3) and etofenamate (n=3). Contact allergies were less frequent (14 reactions). When a 24h occlusion was used prior to irradiation, 53% of sunscreen photoallergic reactions and 36% of NSAID reactions were missed compared with the 48h occlusion. Most participants had a history of photo-exposed site dermatitis or sunscreen/NSAID reaction or had a photosensitivity disease, and 49% of participants had a history of dermatological conditions. All indications for photopatch testing were represented in those with positive photopatch tests, with no specific indicator of those most at risk. Conclusions: Photopatch testing remains an essential investigation for people with suspected photocontact allergies. Based on these study findings, the nature of topical photoallergens appears stable, but vigilance and ongoing review are required. To optimise the pick-up rate of photoallergy, we recommend, if practicable, a 48h occlusion period prior to irradiation. (Clinicaltrials.gov – NCT03812887)
- 23 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1166-1167
Quantity of ultraviolet radiation required to produce erythema: normal ranges in phototesting
This study evaluates whether expressing minimal erythema dose (MED) reference ranges in standard erythema dose (SED) units reduces variability caused by differing ultraviolet wavelengths in phototesting. Analysis of two nonphotosensitive population datasets demonstrated that converting MED from mJ cm−2 to SED substantially compresses interwaveband variation, producing reference ranges closely aligned with the original SED-defining study. These findings support the use of SED-based reference ranges to improve consistency across photodiagnostic services, while emphasizing the continued value of establishing local ranges tailored to specific equipment and populations.
- 23 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1166-1167
Quantity of ultraviolet radiation required to produce erythema: normal ranges in phototesting
This study evaluates whether expressing minimal erythema dose (MED) reference ranges in standard erythema dose (SED) units reduces variability caused by differing ultraviolet wavelengths in phototesting. Analysis of two nonphotosensitive population datasets demonstrated that converting MED from mJ cm−2 to SED substantially compresses interwaveband variation, producing reference ranges closely aligned with the original SED-defining study. These findings support the use of SED-based reference ranges to improve consistency across photodiagnostic services, while emphasizing the continued value of establishing local ranges tailored to specific equipment and populations.
- 7 January 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (6) , 1057-1060
Narrowband ultraviolet B minimal erythema dose reference range
Narrowband ultraviolet B (NB-UVB) phototherapy is a widely used treatment for various dermatological conditions. To optimize dosing and identify abnormal photosensitivity, minimal erythema dose (MED) testing is routinely performed. This retrospective review analysed MED values from 882 patients in Dundee and 188 in London, excluding those with abnormal photosensitivity or repeat tests. Median MED values increased with Fitzpatrick skin phototype (SPT), but significant overlap was observed across SPTs and between centres. Notably, Dundee exhibited statistically lower MED values than London for SPT II/III (P < 0.001). Compared with published volunteer studies, both centres reported lower MEDs, possibly due to differences in dosimetry, erythema assessment or population UV sensitivity. Nonresponder rates were low for SPT I–III but higher in SPT IV–VI, suggesting a need for broader test dose ranges in darker skin types. These findings provide updated reference ranges to inform NB-UVB phototherapy protocols and improve clinical practice.
- 7 January 2026
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 51 (6) , 1057-1060
Narrowband ultraviolet B minimal erythema dose reference range
Narrowband ultraviolet B (NB-UVB) phototherapy is a widely used treatment for various dermatological conditions. To optimize dosing and identify abnormal photosensitivity, minimal erythema dose (MED) testing is routinely performed. This retrospective review analysed MED values from 882 patients in Dundee and 188 in London, excluding those with abnormal photosensitivity or repeat tests. Median MED values increased with Fitzpatrick skin phototype (SPT), but significant overlap was observed across SPTs and between centres. Notably, Dundee exhibited statistically lower MED values than London for SPT II/III (P < 0.001). Compared with published volunteer studies, both centres reported lower MEDs, possibly due to differences in dosimetry, erythema assessment or population UV sensitivity. Nonresponder rates were low for SPT I–III but higher in SPT IV–VI, suggesting a need for broader test dose ranges in darker skin types. These findings provide updated reference ranges to inform NB-UVB phototherapy protocols and improve clinical practice.
- Open Access
- 30 July 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (31) , 16543-16555
The Impact of UVC Light on Indoor Air Chemistry: A Modeling Study
Germicidal ultraviolet light (GUV) is gaining attention for air disinfection, particularly following the COVID-19 pandemic. GUV air cleaning devices use 222 or 254 nm light to remove airborne and surface pathogens from indoor environments, although their impact on indoor chemistry has received limited attention. This modeling study investigates the impact of GUV light on indoor air pollutant concentrations. In a simulated, occupied classroom using a 222 nm lamp with an average room irradiance of 1 μW cm-2, the predicted ozone production rate was 0.33 mg h-1 for an air change rate of 0.5 h-1, leading to surface interactions with occupants and inanimate surfaces that formed secondary products including nonanal, decanal, and 4-oxopentanal. By contrast, ozone concentration increased by 0.19 mg h-1 at 0.5 h-1 in the presence of a 254 nm lamp with an average room irradiance of 15 μW cm-2, primarily due to infiltration. The long-term health benefits of GUV light disinfection need to be quantitatively compared to the health harms due to GUV-induced pollution to allow a more complete assessment of the benefits of this technology.
- 30 July 2025
- Published by American Chemical Society (ACS) in Environmental Science & Technology
- Vol. 59 (31) , 16543-16555
Open AccessThe Impact of UVC Light on Indoor Air Chemistry: A Modeling Study
Germicidal ultraviolet light (GUV) is gaining attention for air disinfection, particularly following the COVID-19 pandemic. GUV air cleaning devices use 222 or 254 nm light to remove airborne and surface pathogens from indoor environments, although their impact on indoor chemistry has received limited attention. This modeling study investigates the impact of GUV light on indoor air pollutant concentrations. In a simulated, occupied classroom using a 222 nm lamp with an average room irradiance of 1 μW cm-2, the predicted ozone production rate was 0.33 mg h-1 for an air change rate of 0.5 h-1, leading to surface interactions with occupants and inanimate surfaces that formed secondary products including nonanal, decanal, and 4-oxopentanal. By contrast, ozone concentration increased by 0.19 mg h-1 at 0.5 h-1 in the presence of a 254 nm lamp with an average room irradiance of 15 μW cm-2, primarily due to infiltration. The long-term health benefits of GUV light disinfection need to be quantitatively compared to the health harms due to GUV-induced pollution to allow a more complete assessment of the benefits of this technology.
- 22 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2282-2284
Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective
Erythropoietic protoporphyria (EPP) is a rare but severely debilitating photodermatosis triggered by exposure to visible and longwave ultraviolet A light, causing intense and prolonged pain that leads to extreme sunlight avoidance and a markedly reduced quality of life. Afamelanotide, the only licensed medication for EPP phototoxicity, is currently being assessed under the Scottish Medicines Consortium’s ultra-orphan pathway, which supports access to treatments for very rare conditions. This is the first report of afamelanotide use in patients with EPP in Scotland. It demonstrates a significant improvement in the time that patients with EPP can spend in sunlight without experiencing painful symptoms and significantly enhancing their overall quality of life.
- 22 July 2025
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 50 (11) , 2282-2284
Afamelanotide in managing cutaneous phototoxicity in erythropoietic protoporphyria: a Scottish perspective
Erythropoietic protoporphyria (EPP) is a rare but severely debilitating photodermatosis triggered by exposure to visible and longwave ultraviolet A light, causing intense and prolonged pain that leads to extreme sunlight avoidance and a markedly reduced quality of life. Afamelanotide, the only licensed medication for EPP phototoxicity, is currently being assessed under the Scottish Medicines Consortium’s ultra-orphan pathway, which supports access to treatments for very rare conditions. This is the first report of afamelanotide use in patients with EPP in Scotland. It demonstrates a significant improvement in the time that patients with EPP can spend in sunlight without experiencing painful symptoms and significantly enhancing their overall quality of life.
- Open Access
- 23 June 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (4) , e70034
Sunscreen and Photoprotection Habits for Patients With Porphyria and Non‐Porphyric Photosensitivity Conditions
Background/Objectives: Individuals with photosensitivity diseases, including porphyria, face significant challenges in managing their condition due to heightened sensitivity to ultraviolet (UV) and visible light. Comprehensive photoprotection strategies are essential and prioritize environmental modifications, behavioral adjustments, protective clothing, and hats. Sunscreens serve as a supplementary measure, particularly for exposed skin areas not otherwise protected. However, the extensive variety of available sunscreen products and limited guidance on their efficacy complicate the selection process. This study evaluates sunscreen use among photosensitive individuals and gathers feedback to inform future service development and research.Methods: A questionnaire was completed by 32 individuals with porphyria (mostly with porphyrias causing skin photosensitivity) and 50 individuals with non‐porphyric photosensitivity conditions, totaling 82 participants. The survey assessed preferences and experiences with sunscreens, focusing on criteria such as protection efficacy, cost, availability, and ease of use. Responses were analyzed to identify trends and challenges in integrating sunscreens into broader photoprotection strategies.Results: Protection efficacy was the primary factor influencing sunscreen choice among photosensitive patients, highlighting its importance alongside other photoprotection measures. The survey revealed considerable variation in sunscreen use. La Roche‐Posay was the most favored brand. While 56% of porphyria patients used sunscreens explicitly labelled for visible light protection, only 11% of non‐porphyric patients did so. Overall, 40% of participants reported issues with sunscreens, and approximately half expressed dissatisfaction with certain products, emphasizing the need for more effective and user‐friendly options.Conclusions: Sunscreens are a critical adjunct to broader photoprotection strategies for photosensitive patients but are not a standalone solution. Particularly for those with porphyrias, effectiveness was regarded as especially important. The variability in product preferences and the frequent difficulties reported highlight the need for improved guidance and accessibility of sunscreens tailored to diverse photosensitivity needs. Future research should focus on developing clear recommendations and expanding options to ensure effective and personalized photoprotection.
- 23 June 2025
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 41 (4) , e70034
Open AccessSunscreen and Photoprotection Habits for Patients With Porphyria and Non‐Porphyric Photosensitivity Conditions
Background/Objectives: Individuals with photosensitivity diseases, including porphyria, face significant challenges in managing their condition due to heightened sensitivity to ultraviolet (UV) and visible light. Comprehensive photoprotection strategies are essential and prioritize environmental modifications, behavioral adjustments, protective clothing, and hats. Sunscreens serve as a supplementary measure, particularly for exposed skin areas not otherwise protected. However, the extensive variety of available sunscreen products and limited guidance on their efficacy complicate the selection process. This study evaluates sunscreen use among photosensitive individuals and gathers feedback to inform future service development and research.Methods: A questionnaire was completed by 32 individuals with porphyria (mostly with porphyrias causing skin photosensitivity) and 50 individuals with non‐porphyric photosensitivity conditions, totaling 82 participants. The survey assessed preferences and experiences with sunscreens, focusing on criteria such as protection efficacy, cost, availability, and ease of use. Responses were analyzed to identify trends and challenges in integrating sunscreens into broader photoprotection strategies.Results: Protection efficacy was the primary factor influencing sunscreen choice among photosensitive patients, highlighting its importance alongside other photoprotection measures. The survey revealed considerable variation in sunscreen use. La Roche‐Posay was the most favored brand. While 56% of porphyria patients used sunscreens explicitly labelled for visible light protection, only 11% of non‐porphyric patients did so. Overall, 40% of participants reported issues with sunscreens, and approximately half expressed dissatisfaction with certain products, emphasizing the need for more effective and user‐friendly options.Conclusions: Sunscreens are a critical adjunct to broader photoprotection strategies for photosensitive patients but are not a standalone solution. Particularly for those with porphyrias, effectiveness was regarded as especially important. The variability in product preferences and the frequent difficulties reported highlight the need for improved guidance and accessibility of sunscreens tailored to diverse photosensitivity needs. Future research should focus on developing clear recommendations and expanding options to ensure effective and personalized photoprotection.
- 20 May 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (3) , 564-566
Far-ultraviolet-C exposure in patients with photosensitivity disorders
Far-ultraviolet-C (far-UVC) radiation, with its germicidal properties, shows promise in reducing the spread of infectious diseases in public and healthcare settings. Emerging evidence suggests minimal risk to human skin and eyes, but its safety for patients with photosensitivity disorders remains uncertain. This study aims to fill this gap by assessing the safety of far-UVC exposure for individuals with these conditions.
- 20 May 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 193 (3) , 564-566
Far-ultraviolet-C exposure in patients with photosensitivity disorders
Far-ultraviolet-C (far-UVC) radiation, with its germicidal properties, shows promise in reducing the spread of infectious diseases in public and healthcare settings. Emerging evidence suggests minimal risk to human skin and eyes, but its safety for patients with photosensitivity disorders remains uncertain. This study aims to fill this gap by assessing the safety of far-UVC exposure for individuals with these conditions.